Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.250
-0.005 (-0.22%)
At close: May 29, 2026, 4:00 PM EDT
2.260
+0.010 (0.44%)
After-hours: May 29, 2026, 4:19 PM EDT
CELZ Market Cap
CELZ has a market cap or net worth of $8.32 million as of May 29, 2026. Its market cap has increased by 56.93% in one year.
Market Cap
8.32M
Enterprise Value
2.48M
1-Year Change
56.93%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $8.32M, a decrease of -48.34%. That is a compound annual growth rate of -13.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 8.30M | 62.75% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
| Dec 3, 2021 | 16.10M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 9.45M |
| PharmaCyte Biotech | 9.20M |
| Imunon | 9.16M |
| Quoin Pharmaceuticals | 8.91M |
| PMGC Holdings | 8.72M |
| Enveric Biosciences | 8.54M |
| Genprex | 8.41M |
| Liminatus Pharma | 8.08M |